Fetal cardiac examination can affect patients' preference on invasive tests: A new data on maternal anxiety indicated karyotyping
- PMID: 30762813
- PMCID: PMC6408130
- DOI: 10.1097/MD.0000000000014599
Fetal cardiac examination can affect patients' preference on invasive tests: A new data on maternal anxiety indicated karyotyping
Abstract
Background: Prenatal screening for aneuploidies has seen great changes over the last 2 decades. But there is still no non-invasive diagnostic test. Therefore, prenatal invasive procedures are still being routinely performed due to maternal anxiety. The association of cardiac anomalies and abnormal findings with aneuploidies has been known for a long time. This prospective study was done to evaluate abnormal fetal cardiac examination (FCE) findings on patients undergoing diagnostic invasive procedures due to maternal anxiety and to assess the predictive value of abnormal cardiac findings on abnormal karyotype.
Materials and methods: Patients who underwent prenatal diagnostic invasive tests due to maternal anxiety indication between March 2013 and September 2016 were included in this study. FCE was performed in the study group immediately prior to invasive tests. Findings of fetal cardiac examination are classified as normal, major-minor cardiac anomalies and soft markers. Fetal karyotypes were compared among groups depending on cardiac findings.
Results: One hundred eighty-two invasive procedures were performed because of maternal anxiety during this period. There were 29 abnormal findings detected on FCE. A total of 7 abnormal karyotypes were detected. FCE was abnormal in 5 of the abnormal karyotypes (71.4%). The presence of a major cardiac anomaly was most predictive for abnormal karyotype (LR+: 96,67, LR-: 0,34). No association was detected between the presence of minor cardiac anomalies and abnormal karyotype. Normal FCE appeared to be a good predictive factor for normal karyotype (LR-: 0.20).
Conclusions: This is the first study evaluating the power of early fetal cardiac examination findings on fetal aneuploidies. This study suggested that the application of fetal cardiac examination findings to genetic counseling for screening aneuploidies may be efficient on patients' preference about invasive tests. Due to the small number of abnormal findings and karyotypes detected (not the large study group), further studies on large study groups are needed to confirm these results.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.Br J Obstet Gynaecol. 1999 Oct;106(10):1029-34. doi: 10.1111/j.1471-0528.1999.tb08109.x. Br J Obstet Gynaecol. 1999. PMID: 10519427
-
Prenatal diagnosis of congenital heart disease and fetal karyotyping.Obstet Gynecol. 1993 May;81(5 ( Pt 1)):679-82. Obstet Gynecol. 1993. PMID: 8469453
-
Evaluation of prenatally diagnosed structural congenital anomalies.J Obstet Gynaecol Can. 2009 Sep;31(9):875-881. doi: 10.1016/S1701-2163(16)34307-9. J Obstet Gynaecol Can. 2009. PMID: 19941713 Review. English, French.
-
Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.J Obstet Gynaecol Can. 2011 Sep;33(9):955-960. doi: 10.1016/S1701-2163(16)35022-8. J Obstet Gynaecol Can. 2011. PMID: 21923994 Review.
References
-
- Ogilvie CM. Prenatal diagnosis for chromosome abnormalities: past, present and future. Pathole Biol 2003;51:156–60. - PubMed
-
- Canick J, Lambert-Messerlian G, Palomaki G, et al. First and Second Trimester Evaluation of Risk (FASTER) trial research consortium. Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol 2006;108:1192–9. - PubMed
-
- Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405–13. - PubMed
-
- Lo YD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical